No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Biotechnology
ISR Immune System Regulation Holding AB (publ), headquartered in Stockholm, Sweden, is dedicated to the discovery and development of pharmaceutical solutions for viral infections. Its current therapeutic pipeline features a Covid-19 vaccine candidate, treatments for Hepatitis B (HBV) and HIV, and an oncology program.
israb.seNo one on the platform currently holds ISR.ST.
No tracked institution reports a position in ISR.ST as of their last filing.
No one on the platform has traded ISR.ST yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| ISR.STISR Immune System Regulation Holding AB (publ) | $1.40 | +0.00% | $97M | — |
| AMNI.STAmniotics AB (publ) | $0.01 | +5.88% | $15M | — |
| ASAP.STAsarina Pharma AB (publ) | $0.03 | -31.03% | $633959 | — |
| COMBI.STCombiGene AB (publ) | $2.47 | -3.89% | $49M | — |
| CYXO.STCyxone AB (publ) | $0.02 | +0.00% | $7M | — |
| IDOGEN.STIdogen AB (publ) | $0.12 | -2.82% | $13M | — |
| KAN.STKancera AB (publ) | $0.30 | +0.00% | $36M | — |
Source: Financial Modeling Prep · peers by sector/industry